XIENCE ALPINE 1125325-38Recalls & reported problems
Abbott Vascular Inc. · XIENCE Alpine Everolimus Eluting Coronary Stent System 3.25 mm x 38 mm / Rapid-Exchange · Class 3 · Implant
All models of XIENCE ALPINE (72)
Data updated Oct 16, 2026 from official FDA records · Editorial policy
- Adverse event reports
- 5
- Deaths reported
- 0
- Injuries reported
- 2
- Recalls naming it
- 0
Summary
The FDA's MAUDE database contains 5 adverse event reports that list this exact device (DI 08717648199486), received between Sep 23, 2016 and Dec 21, 2017 — classified as 2 injuries, 3 malfunctions.
The most frequently reported specific device problem is “Device Dislodged or Dislocated” (1 report).
Reports come from manufacturers, hospitals and patients and are not verified by the FDA. A report does not prove the device caused the event, and counts can't be used to compare devices or estimate failure rates. What reports can and can't tell you · How this data works · Data updated Oct 16, 2026.
Most reported problems
Device problems
- Adverse Event Without Identified Device or Use Problem2
- Device Dislodged or Dislocated1
- Inflation Problem1
- Leak/Splash1
- Positioning Failure1
- Unstable1
Patient problems
- Angina2
- No Patient Involvement2
- No Consequences Or Impact To Patient1
Recent adverse event reports
The 5 most recent of 5 reports, in the reporter's own words as published by the FDA.
MalfunctionDec 21, 2017Positioning Failure; Inflation Problem; Leak/Splash
IT WAS REPORTED THE PROCEDURE WAS TO TREAT A LESION IN AN UNSPECIFIED ARTERY. THE 3.25X38 MM XIENCE ALPINE STENT DELIVERY SYSTEM (SDS) WAS ADVANCED WITHOUT RESISTANCE IN THE PATIENT ANATOMY. HOWEVER, THE BALLOON FAILED TO INFLATE; THE STENT DID NOT DEPLOY. A LEAK WAS SUSPECTED. THE SDS WAS REMOVED FROM THE PATIENT ANATOMY. A NEW XIENCE ALPINE WAS USED TO COMPLETE THE PROCEDURE. THERE WERE NO ADVERSE PATIENT EFFECTS. THERE WAS NO CLINICALLY SIGNIFICANT DELAY IN THE PROCEDURE. NO ADDITIONAL INFORMATION WAS PROVIDED.
Patient problems: No Consequences Or Impact To Patient
MAUDE report 7140085 ↗MalfunctionSep 27, 2017Unstable
IT WAS REPORTED THAT THE 3.25X38 MM XIENCE ALPINE STENT DELIVERY SYSTEM WAS REMOVED FROM THE COIL WHEN IT WAS NOTED THAT THE STENT WAS NOT BETWEEN THE MARKERS. THIS DEVICE WAS NOT USED IN THE PATIENT. A NON-ABBOTT STENT WAS USED TO COMPLETE THE PROCEDURE. NO ADDITIONAL INFORMATION WAS PROVIDED.
Patient problems: No Patient Involvement
MAUDE report 6898521 ↗InjuryAug 29, 2017Adverse Event Without Identified Device or Use Problem
IT WAS REPORTED THAT TWO XIENCE ALPINE STENTS (3.25X38MM AND 3.5X08MM) WERE IMPLANTED ON (B)(6) 2017. ON (B)(6) 2017 THE PATIENT WAS RE-ADMITTED FOR ANGINA AND OTHER UNSPECIFIED CARDIOVASCULAR SYMPTOMS. UNSPECIFIED TREATMENT WAS ADMINISTERED TO THE PATIENT. FINAL PATIENT OUTCOME IS REPORTEDLY UNKNOWN. NO ADDITIONAL INFORMATION WAS PROVIDED.
Patient problems: Angina
MAUDE report 6829060 ↗MalfunctionNov 14, 2016Device Dislodged or Dislocated
IT WAS REPORTED THAT DURING REMOVAL OF THE PROTECTIVE SHEATH FROM THE 3.25 X 38 MM XIENCE ALPINE STENT DELIVERY SYSTEM, THE STENT IMPLANT DISLODGED AND WAS LOCATED INSIDE THE SHEATH. THE DEVICE COULD NOT BE USED ON THE PATIENT. THERE WAS NO REPORTED RESISTANCE DURING REMOVAL FROM THE DISPENSER OR PROTECTIVE SHEATH, NOR WAS FORCE APPLIED OR ANY MANIPULATION OF THE STENT IMPLANT. THERE WAS NO PATIENT INVOLVEMENT. ANOTHER STENT DELIVERY SYSTEM WAS ABLE TO BE USED SUCCESSFULLY FOR THE CASE. NO CLINICALLY SIGNIFICANT DELAY IN THE PROCEDURE WAS REPORTED. NO ADDITIONAL INFORMATION WAS PROVIDED.
Patient problems: No Patient Involvement
MAUDE report 6100736 ↗InjurySep 23, 2016Adverse Event Without Identified Device or Use Problem
IT WAS REPORTED THAT A 3.25 X 38 MM XIENCE ALPINE STENT WAS IMPLANTED ON (B)(6) 2016. ON (B)(6) 2016, THE PATIENT WAS RE-ADMITTED WITH ANGINA. THE PATIENT WAS DISCHARGED WITHOUT TREATMENT. NO ADDITIONAL INFORMATION WAS PROVIDED.
Patient problems: Angina
MAUDE report 5975538 ↗
Other Coronary drug-eluting stent devices
- SYNERGY™ H7493926038300Boston Scientific Corporation · Coronary drug-eluting stent8 deaths124 reports
- SYNERGY™ H7493926016300Boston Scientific Corporation · Coronary drug-eluting stent7 deaths106 reports
- SYNERGY™ H7493926020300Boston Scientific Corporation · Coronary drug-eluting stent9 deaths90 reports
- XIENCE Sierra™ 1550350-33Abbott Vascular Inc. · Coronary drug-eluting stent1 recall32 reports
- SYNERGY™ H7493926016250Boston Scientific Corporation · Coronary drug-eluting stent6 deaths82 reports
- Resolute Onyx™ RONYX30022UXMedtronic, Inc. · Coronary drug-eluting stent6 deaths76 reports
- SYNERGY™ H7493926024300Boston Scientific Corporation · Coronary drug-eluting stent3 deaths75 reports
- Resolute Onyx™ RONYX30015UXMedtronic, Inc. · Coronary drug-eluting stent3 deaths73 reports
Sources and updates
- Device record: FDA GUDID, file dated Oct 13, 2026 · View this device in AccessGUDID ↗
- Adverse event reports: FDA MAUDE, file dated Oct 14, 2026 · each report above links to its original FDA record
- Recalls: FDA Medical Device Recalls, file dated Oct 16, 2026
- Page last rebuilt: Oct 16, 2026. Data downloaded through openFDA, which notes it is not validated for clinical or regulatory use.
How reports and recalls are matched · Editorial policy · Report an error on this page